Gene-editing therapy aimed at two targets -- HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells -- can effectively eliminate HIV infection, new research ...

Scientists at Temple University say they have gotten closer to a cure for HIV by combining a new gene editing therapy with antiretroviral drugs. The researchers say the human immunodeficiency virus ...

In a study published May 1 in Proceedings of the National Academy of Sciences, a research team led by scientists from the Lewis Katz School of Medicine at Temple University and the University of ...

Tests in animal models by researchers at the Lewis Katz School of Medicine at Temple University, and at the University of Nebraska Medical Center (UNMC) have shown how gene editing two targets, HIV-1 ...

**Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the ...

Our genomes contain two copies of the CCR5 gene. It is known that people who carry two defective copies of this gene are highly resistant to HIV. But this double mutation of the CCR5 gene, which a ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

In an ongoing clinical trial, researchers are testing whether just one dose of a new gene therapy that might effectively cure human immunodeficiency virus (HIV) infections is safe in humans. According ...

Since the first reported cases in 1981, the human immunodeficiency virus (HIV) infected approximately 86 million people and resulted in the deaths of tens of millions of people from acquired ...

A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram ...